When we break a bone, the damage is obvious. But not every health condition in life is so clear-cut. Many ailments are considered a "silent disease" because they don't have obvious symptoms. Instead, ...
A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...